We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.14B
AUM Growth
+$218M
Cap. Flow
+$172M
Cap. Flow %
8.07%
Top 10 Hldgs %
26.01%
Holding
154
New
13
Increased
61
Reduced
17
Closed
10

Top Buys

Rank Stock Value
1
GTT
GTT Communications, Inc.
GTT
+$19.7M
2
ANET icon
Arista Networks
ANET
+$17.8M
3
VRNS icon
Varonis Systems
VRNS
+$17.3M
4
ROP icon
Roper Technologies
ROP
+$16.3M
5
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$15.9M

Top Sells

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$16.9M
2
TWLO icon
Twilio
TWLO
+$7.85M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.12M
4
LOXO
Loxo Oncology, Inc
LOXO
+$5.96M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$5.72M

Sector Composition

Rank Sector Weight
1 Healthcare 38.18%
2 Technology 17.61%
3 Consumer Discretionary 12.18%
4 Industrials 9.62%
5 Utilities 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XIFR
26
XPLR Infrastructure LP
XIFR
$1.18B
$32.1M 1.5%
802,200
+19,600
+3% +$793K
STKL
27
DELISTED
SunOpta
STKL
$30.5M 1.43%
4,300,540
+398,515
+10% +$2.96M
SGEN
28
DELISTED
Seagen Inc. Common Stock
SGEN
$29.2M 1.36%
557,000
+32,000
+6% +$1.74M
VRNS icon
29
Varonis Systems
VRNS
$5.25B
$29M 1.36%
1,437,000
+933,000
+185% +$17.3M
FIVN icon
30
FIVE9
FIVN
$1.77B
$26.6M 1.25%
894,000
+318,000
+55% +$8.71M
LOXO
31
DELISTED
Loxo Oncology, Inc
LOXO
$26.4M 1.24%
229,000
-56,000
-20% -$5.96M
IDTI
32
DELISTED
Integrated Device Technology I
IDTI
$25.2M 1.18%
826,000
– –
GTT
33
DELISTED
GTT Communications, Inc.
GTT
$25M 1.17%
441,000
+398,754
+944% +$19.7M
SNA icon
34
Snap-on
SNA
$20.9B
$24.3M 1.14%
164,470
+105
+0.1% +$17.3K
LII icon
35
Lennox International
LII
$18.8B
$24.1M 1.13%
118,000
+43,000
+57% +$8.95M
ARW icon
36
Arrow Electronics
ARW
$10.9B
$22.7M 1.06%
295,000
– –
ELLI
37
DELISTED
Ellie Mae Inc
ELLI
$22.2M 1.04%
242,000
– –
XLRN
38
DELISTED
Acceleron Pharma
XLRN
$20.7M 0.97%
529,900
-124,000
-19% -$5.27M
JELD icon
39
JELD-WEN Holding
JELD
$94.8M
$19.7M 0.92%
644,100
+137,600
+27% +$4.99M
PANW icon
40
Palo Alto Networks
PANW
$264B
$18.9M 0.88%
624,000
+84,000
+16% +$2.33M
CAFD
41
DELISTED
8point3 Energy Partners LP
CAFD
$18.9M 0.88%
1,553,600
+92,200
+6% +$1.22M
ONCE
42
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$18M 0.84%
270,000
-54,000
-17% -$3.12M
PFPT
43
DELISTED
Proofpoint, Inc.
PFPT
$18M 0.84%
158,000
– –
PEGI
44
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$17.9M 0.84%
1,034,500
+10,000
+1% +$194K
TTD icon
45
Trade Desk
TTD
$8.13B
$17.9M 0.84%
3,600,000
-3,290,000
-48% -$16.9M
ANET icon
46
Arista Networks
ANET
$219B
$16.9M 0.79%
+1,056,000
New +$17.8M
SRPT icon
47
Sarepta Therapeutics
SRPT
$1.66B
$16.7M 0.78%
226,000
+65,000
+40% +$4.33M
IPHI
48
DELISTED
INPHI CORPORATION
IPHI
$16.7M 0.78%
555,000
– –
APTV icon
49
Aptiv
APTV
$12B
$16.7M 0.78%
196,500
+38,500
+24% +$3.49M
STML
50
DELISTED
Stemline Therapeutics, Inc.
STML
$16.6M 0.78%
1,086,400
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $6.07B AUM 11.2% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Eventide Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Eventide Asset Management held 154 positions worth $2.14B, up 11% from $1.92B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $172M of net new capital in Q1 2018, opening 13 new positions and adding to 61 existing holdings. Its largest new stake was Arista Networks: 1,056,000 shares worth $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Trade Desk, an estimated $16.9M trimmed.

  • Eventide Asset Management's largest Q1 2018 buy was Arista Networks: 1,056,000 shares worth $16.9M.
  • Eventide Asset Management added most to GTT Communications, Inc. in Q1 2018, an estimated $19.7M increase.
  • Eventide Asset Management's biggest Q1 2018 reduction was Trade Desk, cutting an estimated $16.9M.
  • Eventide Asset Management fully exited Protagonist Therapeutics in Q1 2018, selling an estimated $5.72M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $2.14B portfolio in Q1 2018.
  • Eventide Asset Management opened 13 new positions and closed 10 in Q1 2018.
  • Eventide Asset Management's portfolio value rose 11% quarter-over-quarter to $2.14B.

Based on Eventide Asset Management's 13F filing for Q1 2018, filed 15 May 2018.